BioCatalystWatch
DTILWorkspace / DTIL / OverviewCompany library
PRECISION BIOSCIENCES INC logo

PRECISION BIOSCIENCES INC

PRECISION BIOSCIENCES INC (DTIL)

Website

Price
Market cap
Next catalystExpected 2026PBGENE-PMM · Phase 1 dataCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

PBGENE-DMD

Dystrophin exons 45-55

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

CD19

PBGENE-HBV

HBV cccDNA × Integrated HBV DNA

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

PBGENE-HBV

HBV cccDNA × Integrated HBV DNA

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

PBGENE-PMM

m.3243G mtDNA

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

PBGENE-PMM

m.3243G mtDNA

PreINDP1P2P3FilingApproved
Upcoming / outlook

PBGENE-DMD

Dystrophin exons 45-55

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

PBGENE-HBV

HBV cccDNA × Integrated HBV DNA

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

PBGENE-HBV

HBV cccDNA × Integrated HBV DNA

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

CD19

Other pipelines

PBGENE-HBV

HBV cccDNA × Integrated HBV DNA

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved
PBCAR269B

BCMA

Partner / License out

CD19

PreINDP1P2P3FilingApproved

History / paused

CD19

PreINDP1P2P3FilingApproved

CD19

PreINDP1P2P3FilingApproved

m.3243G mtDNA

PreINDP1P2P3FilingApproved

PCSK9

PreINDP1P2P3FilingApproved

CD20

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

DTIL SEC archive